Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol

• Status: Not yet recruiting
• Trial end date: 2023-05-01
• Target enrollment: 0
• Participant gender: All

Summary

examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sarah Abdelbar Mahmoud

Criteria

Inclusion Criteria:

• Medically fit and cooperative children.

• Pediatric patients aged 4-6 years.

• A deep carious lesion in vital primary molars.

• Absence of clinical signs and symptoms of pulpal exposure.

• Absence of radiographic signs and symptoms of people degeneration.

• Positive parental informed consent.

Exclusion Criteria:

Uncooperative children.

• Medically compromised children.

• Presence of clinical signs and symptoms of pulpal exposure.

• Presence of radiographic signs and symptoms of pulp degeneration.

• Physiologic root resorption more than one-third.